Reuters logo
9 个月内
BRIEF-Opexa Therapeutics receives notice from Ares Trading S.A. Unit of Merck Serono
2016年11月25日 / 下午12点47分 / 9 个月内

BRIEF-Opexa Therapeutics receives notice from Ares Trading S.A. Unit of Merck Serono

1 分钟阅读

Nov 25 (Reuters) - Opexa Therapeutics Inc

* Opexa Therapeutics - On Nov 23, co received notice from Ares Trading S.A. Unit of Merck Serono

* Opexa Therapeutics - Notice says Merck Serono would not be exercising its option to acquire exclusive worldwide license to co's Tcelna Program for MS

* Says as a result of receiving notice from Merck Serono, agreement automatically expired upon receipt Source text: [bit.ly/2gtrjR7] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below